EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients

Amina A Abdelhadi, Hidenori Ogata iD, Xu Zhang, Takumi Tashiro, Ryo Yamasaki, Jun-Ichi Kira iD, Noriko Isobe

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Amina A Abdelhadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Autoantibodies, Epitope Mapping, Nerve Growth Factors. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Japan Society for the Promotion of Science (JSPS) KAKENHI, Egyptian Ministry of Higher Education, The Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Autoimmune nodopathy (AN), a newly recognized disease entity, is an immune‐mediated polyneuropathy involving autoantibodies against cell adhesion molecules located in nodes of Ranvier and paranodal regions, such as neurofascin 186 (NF186) and neurofascin 155 (NF155). The present study aimed to identify the epitopes for autoantibodies against NF155 in a large cohort of Japanese patients with anti‐NF155 antibody‐positive (anti‐NF155+) AN.

Methods

Human embryonic kidney 293 cells stably expressing NF155, NF186, or the third to fourth fibronectin type III domain region (Fn3‐Fn4) of NF155, as well as cells transiently expressing Fn3, Fn4, or the shorter Fn3‐Fn4 region of NF155, were developed. Western blotting and flow cytometric cell‐based assay (CBA) analyses were performed to determine the expression levels of the proteins and identify their target epitopes in serum samples from 100 IgG4 anti‐NF155+ patients, four non‐IgG4 anti‐NF155+ patients, and eight healthy controls.

Results

The expression levels of NF186, NF155, Fn3‐Fn4 of NF155, and the other truncation variants of NF155 were confirmed by western blotting and flow cytometric CBA. Flow cytometric CBA analysis showed that the autoantibodies in all 104 anti‐NF155+ patients bound to Fn3‐Fn4. No autoantibodies reacted with NF186, Fn4, or shorter Fn3‐Fn4, although the autoantibodies in one IgG4 anti‐NF155+ patient (1.0%) recognized Fn3 in addition to Fn3‐Fn4. Western blotting analysis of representative samples generally reproduced the CBA results.

Interpretation

The present study involving a large cohort of patients clarified that the primary epitope for anti‐NF155 antibodies is located in the Fn3‐Fn4 region, but not in the Fn3 or Fn4 domains alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Adhesion MoleculesAutoantibodiesEpitope MappingNerve Growth FactorsAutoimmune DiseasesHumansFemaleMaleMiddle AgedHEK293 CellsAdultCohort StudiesAgedEpitopesYoung Adult

Stichwörter der Autor:innen

IgG4autoantibodyautoimmune nodopathyepitopeneurofascin 155

Substanzen

Cell Adhesion MoleculesAutoantibodiesNFASC protein, humanNerve Growth FactorsEpitopes

Autor:innen und Institutionen

  • Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Okawa, Japan.

ORCID-Profile: Hidenori Ogata, Jun-Ichi Kira

Förderung

  • The Japan Society for the Promotion of Science (JSPS) KAKENHI
  • Egyptian Ministry of Higher Education
  • The Japan Agency for Medical Research and Development (AMED)
  • Japan Society for the Promotion of Science
  • Ministry of Higher Education
  • Japan Agency for Medical Research and Development

Zitieren

APA

Abdelhadi, A. A., Ogata, H., Zhang, X., Tashiro, T., Yamasaki, R., Kira, J. I., & Isobe, N. (2025). Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70036

Vancouver

Abdelhadi AA, Ogata H, Zhang X, Tashiro T, Yamasaki R, Kira JI, et al. Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70036

BibTeX
@article{Abdelhadi2025,
  author = {Abdelhadi, Amina A and Ogata, Hidenori and Zhang, Xu and Tashiro, Takumi and Yamasaki, Ryo and Kira, Jun-Ichi and Isobe, Noriko},
  title = {Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70036}
}
Kostenlos starten →